Diagnostic and prognostic biomarkers for Parkinsons disease

$677,884U01FY2013NSNIH

Ut Southwestern Medical Center, Dallas TX

Investigators

Linked publications & trials

Paper 39606324 Paper 38487808 Paper 37986893 Paper 35365675 Paper 35291020 Paper 34385975 Paper 33897604 Paper 33730626 Paper 33708010 Paper 33538517 Paper 31741550 Paper 31603904 Paper 30111645 Paper 28644039 Paper 27830568 Paper 27812535 Paper 26442452 Paper 26271532 Paper 25082782

Abstract

DESCRIPTION (provided by applicant): Biomarkers that can detect PD pathology and that can detect disease progression will be most helpful for patient care and proper clinical trial design. As part of the NINDS Parkinson's Disease Biomarkers Program, we seek to collect biological specimens from PD patients and identify serum biomarkers for disease identification and tracking disease progression.

View original record on NIH RePORTER →